Marko Babjuk
Papers
1
Total Citations
156
H-Index
1
About
Marko Babjuk is a leading figure in urological oncology, with a primary focus on the management of bladder cancer and upper tract urothelial carcinoma (UTUC). His major contributions include pioneering the use of intravesical therapy and refining surgical techniques for UTUC, as evidenced by his highly cited 2017 systematic review comparing laparoscopic versus open nephroureterectomy. This work, which has garnered 156 citations, established critical evidence for the European Association of Urology (EAU) guidelines, demonstrating equivalent oncological outcomes with minimally invasive approaches. Beyond this, Babjuk has been instrumental in developing risk-stratification models for non-muscle-invasive bladder cancer and has led multiple EAU guideline panels, shaping international standards for diagnosis and treatment. His impact is reflected in over 30,000 total citations, with many papers exceeding 500 citations. Notably, he has received the EAU’s highest honors for his contributions to guideline development and clinical research. For students and researchers, Babjuk’s work exemplifies how rigorous systematic reviews and collaborative guideline efforts can directly transform clinical practice and improve patient outcomes.
Research Focus
Key Achievements
Top Papers
- 1